4.8 Article

A Stilbene That Binds Selectively to Transthyretin in Cells and Remains Dark until It Undergoes a Chemoselective Reaction To Create a Bright Blue Fluorescent Conjugate

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 132, 期 45, 页码 16043-16051

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ja104999v

关键词

-

资金

  1. NIH [DK46335]
  2. Skaggs Institute for Chemical Biology
  3. Lita Annenberg Hazen Foundation

向作者/读者索取更多资源

We describe a non-fluorescent, second generation stilbene that very selectively binds to transthyretin in complex biological environments and remains dark until it chemoselectively reacts with the pK(a)-perturbed Lys-15 epsilon-amino group of transthyretin to form a bright blue fluorescent conjugate. Stilbene A2 is mechanistically unusual in that it remains non-fluorescent in cell lysates lacking transthyretin, even though there is likely some proteome binding. Thus, it is especially useful for cellular imaging, as background fluorescence is undetectable until A2 reacts with transthyretin. The mechanistic basis for the effective lack of environment-sensitive fluorescence of A2 when bound to, but before reacting with, transthyretin is reported. Stilbene A2 exhibits sufficiently rapid transthyretin conjugation kinetics at 37 degrees C to enable pulse-chase experiments to be performed, in this case demonstrating that transthyretin is secreted from HeLa cells. As the chase compound, we employed Cl, a cell-permeable, highly selective, non-covalent, transthyretin-binding dihydrostilbene that cannot become fluorescent. The progress reported is viewed as a first and necessary step toward our long-term goal of creating a one-chain, one-binding-site transthyretin tag, whose fluorescence can be regulated by adding A2 or an analogous molecule. Fusing proteins of interest to a one-chain, one-binding-site transthyretin tag regulated by A2 should be useful for studying folding, trafficking, and degradation in the cellular secretory pathway, utilizing pulse-chase experiments. Immediate applications of A2 include utilizing its conjugate fluorescence to quantify transthyretin concentration in human plasma, reflecting nutritional status, and determining the binding stoichiometry of kinetic stabilizer drugs to transthyretin in plasma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Epigenetic plasticity and redox regulation of neural stem cell state and fate

Emmy Xue Yun Tay, Kimberly Chia, Derrick Sek Tong Ong

Summary: Neural stem cells are crucial for normal brain development and are regulated by redox and epigenetic mechanisms. How this crosstalk impacts NSC activity remains poorly understood, as well as their contribution to brain ageing and neurodegenerative diseases. Therapeutic opportunities based on redox and epigenetic regulations are highlighted for rescuing NSC dysfunctions.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Multidisciplinary Sciences

A chemical biology approach reveals a dependency of glioblastoma on biotin distribution

Jeehyun Yoon, Oleg Grinchuk, Srinivasaraghavan Kannan, Melgious Jin Yan Ang, Zhenglin Li, Emmy Xue Yun Tay, Ker Zhing Lok, Bernice Woon Li Lee, You Heng Chuah, Kimberly Chia, Roberto Tirado Magallanes, Chenfei Liu, Haonan Zhao, Jin Hui Hor, Jhin Jieh Lim, Touati Benoukraf, Tan Boon Toh, Edward Kai-Hua Chow, Jean-Paul Kovalik, Jianhong Ching, Shi-Yan Ng, Ming Joo Koh, Xiaogang Liu, Chandra Shekhar Verma, Derrick Sek Tong Ong

Summary: The study reveals the dependency of GBM on biotin distribution, suggesting that rational cotargeting of biotin-dependent metabolism and epigenetic pathways may be explored for GSC eradication.

SCIENCE ADVANCES (2021)

Article Chemistry, Multidisciplinary

Deciphering Nanoparticle Trafficking into Glioblastomas Uncovers an Augmented Antitumor Effect of Metronomic Chemotherapy

Melgious Jin Yan Ang, Jeehyun Yoon, Mingzhu Zhou, Han-Lin Wei, Yi Yiing Goh, Zhenglin Li, Jia Feng, Haifang Wang, Qianqian Su, Derrick Sek Tong Ong, Xiaogang Liu

Summary: Nanoparticles modified with ligands can cross the blood-brain barrier, endocytose into the lysosomes of glioblastoma cells, and undergo endolysosomal escape under photochemical ionization. Metronomic chemotherapy using dual-drug-loaded nanocarriers can induce an enhanced antitumor effect 3.5 times greater than standard chemotherapy.

ADVANCED MATERIALS (2022)

Article Biochemistry & Molecular Biology

E2F and STAT3 provide transcriptional synergy for histone variant H2AZ activation to sustain glioblastoma chromatin accessibility and tumorigenicity

Jeehyun Yoon, Oleg Grinchuk, Roberto Tirado-Magallanes, Zhen Kai Ngian, Emmy Xue Yun Tay, You Heng Chuah, Bernice Woon Li Lee, Jia Feng, Karen Carmelina Crasta, Chin Tong Ong, Touati Benoukraf, Derrick Sek Tong Ong

Summary: The histone variant H2AZ is overexpressed in glioblastomas (GBM) and glioma stem cells (GSCs), promoting their proliferation and tumorigenicity. E2F1 and STAT3 synergistically activate H2AZ gene transcription in GSCs, and an E2F/STAT3 inhibitor combination shows promise in suppressing GSC tumorigenicity in GBM treatment.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

Small molecule protein binding to correct cellular folding or stabilize the native state against misfolding and aggregation

Fabrizio Chiti, Jeffery W. Kelly

Summary: Protein misfolding diseases are caused by structural abnormalities in proteins, and specific small molecules have been approved to stabilize the folded state of these proteins, providing a promising approach to treat such diseases.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2022)

Article Chemistry, Medicinal

Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site

Nicholas L. Yan, Reji Nair, Alan Chu, Ian A. Wilson, Kristen A. Johnson, Gareth J. Morgan, Jeffery W. Kelly

Summary: This study investigates the potential of finding small molecule kinetic stabilizers in immunoglobulin light chain amyloidosis, identifying coumarin-based compounds with potential therapeutic effects. Structural-activity relationship data reveals that these compounds bind at different sites in the LC dimer, exerting unique stabilizing effects on LCs.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2022)

Review Biochemistry & Molecular Biology

Inverse Drug Discovery identifies weak electrophiles affording protein conjugates

Gabriel M. Kline, Karina Nugroho, Jeffery W. Kelly

Summary: In this review, we examine the application of Inverse Drug Discovery method using organic compounds of intermediate complexity harboring Sulfur(VI)-fluoride exchange (SuFEx) electrophiles to expand the cellular proteins that can be targeted covalently.

CURRENT OPINION IN CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors

Meng Wang, Edmund Cotter, Ya-Juan Wang, Xu Fu, Angela L. Whittsette, Joseph W. Lynch, R. Luke Wiseman, Jeffery W. Kelly, Angelo Keramidas, Ting-Wei Mu

Summary: This study demonstrates that pharmacologically enhancing endoplasmic reticulum (ER) proteostasis can increase the assembly, trafficking, and surface expression of variant GABA(A) receptors, offering a potential opportunity to mitigate pathology associated with genetic epilepsy and other disease-associated variant ion channels.

CELL AND BIOSCIENCE (2022)

Article Cell Biology

ATF6 Activation Reduces Amyloidogenic Transthyretin Secretion through Increased Interactions with Endoplasmic Reticulum Proteostasis Factors

Jaleh S. Mesgarzadeh, Isabelle C. Romine, Ethan M. Smith-Cohen, Julia M. D. Grandjean, Jeffery W. Kelly, Joseph C. Genereux, R. Luke Wiseman

Summary: This study identified ER proteostasis factors involved in ATF6-dependent reductions in destabilized TTR secretion through a mass-spectrometry-based interactomics approach. Activation of ATF6 reduces the secretion and subsequent aggregation of amyloidogenic TTR through increased interactions with ATF6-regulated ER proteostasis factors including BiP and PDIA4. PDIA4 retains destabilized TTR in the ER through a redox-independent mechanism. These findings provide a mechanistic basis for the therapeutic targeting of ATF6 activation to improve treatments for TTR-related amyloid diseases.
Article Cell Biology

PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation

Jiaqing Chen, Li Zou, Guang Lu, Oleg Grinchuk, Lei Fang, Derrick Sek Tong Ong, Reshma Taneja, Choon-Nam Ong, Han-Ming Shen

Summary: This study reveals the important role of PFKP in non-small-cell lung cancer (NSCLC), showing that PFKP interacts with AMPK to promote mitochondrial recruitment of AMPK and enhance phosphorylation of ACC2, ultimately promoting long-chain fatty acid oxidation and cancer cell survival under glucose starvation.

CELL DISCOVERY (2022)

Article Geriatrics & Gerontology

Analysis of lumbar spine stenosis specimens for identification of amyloid

Mathew S. Maurer, Dia Smiley, Eli Simsolo, Fabrizio Remotti, Angela Bustamante, Sergio Teruya, Stephen Helmke, Andrew J. Einstein, Ronald Lehman, Jon T. Giles, Jeffery W. Kelly, Felix Tsai, William S. Blaner, Pierre-Jacques Brun, Ron Riesenburger, James Kryzanski, Cindy Varga, Ayan R. Patel

Summary: Lumbar spinal stenosis (LSS) is a common reason for spine surgery in older adults, with amyloid detected in over one third of patients, especially in those over 75 years old. Age, clinical symptoms, cardiac biomarkers, and other parameters did not differ significantly between patients with and without amyloid.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2022)

Article Biochemistry & Molecular Biology

SETDB1 acts as a topological accessory to Cohesin via an H3K9me3-independent, genomic shunt for regulating cell fates

Tushar Warrier, Chadi El Farran, Yingying Zeng, Benedict Shao Quan Ho, Qiuye Bao, Zi Hao Zheng, Xuezhi Bi, Huck Hui Ng, Derrick Sek Tong Ong, Justin Jang Hann Chu, Amartya Sanyal, Melissa Jane Fullwood, James J. Collins, Hu Li, Jian Xu, Yuin-Han Loh

Summary: SETDB1 regulates lineage-specific genes and endogenous retroviral elements through H3K9me3 deposition. In addition, it co-regulates target gene expression and genome topology with the topological regulator Cohesin at DiSCs, which are regions proximal to gene promoters involved in embryonic stem cell pluripotency and lineage development. This discovery is important for understanding the maintenance and differentiation of embryonic stem cells.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

Tafamidis polyneuropathy amelioration requires modest increases in transthyretin stability even though increases in plasma native TTR and decreases in non-native TTR do not predict response

Cecilia Monteiro, Jaleh S. Mesgarzadeh, Joao Anselmo, Joana Fernandes, Marta Novais, Carla Rodrigues, David L. Powers, Evan T. Powers, Teresa Coelho, Jeffery W. Kelly

Summary: This study explored the relationship between TTR stabilization markers and clinical efficacy of tafamidis treatment. The results showed an increase in native TTR concentration and a decrease in non-native TTR concentration. However, changes in native and non-native TTR levels were not correlated with clinical response to tafamidis. Successful tafamidis therapy requires moderate TTR stabilization, and male patients may benefit from higher doses of tafamidis.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2023)

Article Biochemistry & Molecular Biology

Characterising diflunisal as a transthyretin kinetic stabilizer at relevant concentrations in human plasma using subunit exchange

Felix J. J. Tsai, Luke T. T. Nelson, Gabriel M. M. Kline, Marcus Jager, John L. L. Berk, Yoshiki Sekijima, Evan T. T. Powers, Jeffery W. Kelly

Summary: This study investigated the plasma concentrations of diflunisal and its efficacy in treating TTR polyneuropathy, finding that at a certain concentration, diflunisal can effectively slow down TTR dissociation rate and inhibit aggregation.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2023)

Article Oncology

Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma

Nandini Karthik, Jane Jia Hui Lee, Joshua Ling Jun Soon, Hsin Yao Chiu, Amos Hong Pheng Loh, Derrick Sek Tong Ong, Wai Leong Tam, Reshma Taneja

Summary: This study reveals that histone variant H3.3 is overexpressed in alveolar rhabdomyosarcoma (ARMS), impacting the migration and invasion ability of tumor cells and correlating with metastasis and prognosis in ARMS. Mechanistically, melanoma cell adhesion molecule (MCAM) is identified as a direct downstream target of H3.3, and its overexpression rescues cell migration and invasion in H3F3A-depleted cells. Furthermore, G9a, an upstream regulator of H3F3A, is discovered. This study uncovers a novel H3.3-dependent axis and establishes the potential of MCAM as a therapeutic target for high-risk ARMS patients.

JOURNAL OF PATHOLOGY (2023)

暂无数据